Event dossier

Eli Lilly’s Foundayo obesity pill eases sleep apnea in late-stage trial, paving way for approval

Lilly plans to file by the end of the year for U.S. approval of the daily pill for moderate-to-severe obstructive sleep apnea in adults with obesity.

1 report1 sourceNov 9, 2026, 2:30 PM
FilterCNBC
Clustered coverageCNBC
Coverage timeline1
Coverage timeline

Coverage timeline

Ranked reports inside the event cluster. Open any publisher link to read the original coverage.

CNBCNov 9, 2026, 2:30 PM

Eli Lilly’s Foundayo obesity pill eases sleep apnea in late-stage trial, paving way for approval

Lilly plans to file by the end of the year for U.S. approval of the daily pill for moderate-to-severe obstructive sleep apnea in adults with obesity.

Related events

Related events

Nearby clusters pulled from title, summary, and keyword similarity in PostgreSQL.

El Psy Congroo